Corrigendum: Prevalence of Common Mental Disorders in South Asia: A Systematic Review and Meta-Regression Analysis (Frontiers in Psychiatry, (2020), 11, (573150), 10.3389/fpsyt.2020.573150)

Abstract

In the original article, there was amistake in Table 1 “Pooled prevalence ofmental disorders in South Asia” as published. Prevalence estimates of five of the psychiatric disorders were wrongly formatted with misplaced decimal points. The corrected Table 1 “Pooled prevalence of mental disorders in South Asia” appears below. In the original article, there was a mistake in Table 3 “Subgroup analyses presenting several factors associated with the prevalence of CMDs in included studies” as published. Prevalence estimates for subgroups of sampling methods were wrongly formatted. The corrected Table 3 “Subgroup analyses presenting several factors associated with the prevalence of CMDs in included studies” appears below. In the original article, there was an error. Prevalence estimates for panic disorder was wrongly formatted with misplaced decimal points in the results section of abstract and main text. A correction has been made to the Research section, Paragraph Number 2: We assessed the pooled prevalence for 17 differentmental disorders over a period of 10 years. All the outcomes presented significant heterogeneity ranging from 0% to 99.79% for stimulant use and alcohol abuse, respectively. The prevalence of depressive symptoms was reported in 135 studies (I2 = 99.53%) yielding a prevalence of 26.4% among 173,449 participants. Alcohol abuse was reported in 43 studies yielding a prevalence of 12.9% (8.8%-18.6%, I2 =99.79%, n=107893); anxiety 25.8% (19.4%to 33.5%, I2 =99.57%, n=70,058); tobacco smoking 18.6%(14.3%to 24%, I2 =99.58%, n= 84965); PTSD 17.2% (11% to 25.9%, I2 = 99.55%, n = 42298); mixed anxiety and depression 28.4% (13.9% to 49.3%, I2 = 99.41%, n = 11102); suicidal behaviors 6.4% (3.1% to 12.4%, I2 = 99.41%, n = 25043); misuse of opiates 0.8% (0.2% to 2.5%, I2 = 99.06%, n = 37304); tobacco chewing 21.0% (14.0% to 30.3%, I2 = 98.49%, n = 10586); use of cannabis 3.4% (1.5% to 7.3%, I2 = 97.48%, n = 10977); GAD 2.9% (0.3% to 26.5%, I2 = 99.57%, n = 70058); bipolar disorder 0.6% (0.3% to 1.0%, I2 = 78.21%, n = 7197); IV drug abuse 2.5% (0.1% to 32.1%, I2 = 99.72%, n = 15049); Panic disorder 1.3% (0.5% to 3.4%, I2 = 95.43%, n = 28087); stimulant use 0.9% (0.5% to 1.6%, I2 = 0%, (Figure presented.). n = 1414); OCD 1.6% (0.4% to 5.5%, I2 = 96.57%, n = 8784) and phobic disorders 1.8% (0.4% to 7.1%, I2 = 98.16%, n = 27754). Supplementary Figures 1–12 represent the forest plots for the above-mentioned disorders. In the original article, there was an error. Prevalence estimates for panic disorder was wrongly formatted with misplaced decimal points in the results section of abstract and main text. A correction has been made to the abstract: A prevalence of depressive symptoms was 26.4% among 173,449 participants, alcohol abuse was 12.9% (n = 107,893); anxiety 25.8%(n=70,058); tobacco smoking 18.6%(n=84,965); PTSD 17.2% (n = 42,298); mixed anxiety and depression 28.4% (n = 11,102); suicidal behaviors 6.4% (n = 25,043); misuse of opiates 0.8% (n = 37,304); tobacco chewing 21.0% (n = 10,586); use of cannabis 3.4% (n = 10,977); GAD 2.9% (n = 70,058); bipolar disorder 0.6% (n = 7,197); IV drug abuse 2.5% (n = 15,049); panic disorder 1.3% (n = 28,087); stimulant use 0.9% (n = 1,414); OCD 1.6% (n = 8,784) and phobic disorders 1.8% (n = 27,754). The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.